Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002516438 | SCV003268813 | pathogenic | Epilepsy | 2024-12-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg207*) in the PIGQ gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PIGQ are known to be pathogenic (PMID: 24463883, 25558065). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of PIGQ-congenital disorder of glycosylation (PMID: 25558065). ClinVar contains an entry for this variant (Variation ID: 183339). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Genomic Medicine Center of Excellence, |
RCV000162174 | SCV000196460 | likely pathogenic | Global developmental delay; Optic atrophy; Intractable seizure | 2014-12-01 | no assertion criteria provided | research | |
OMIM | RCV000850139 | SCV000992303 | pathogenic | Developmental and epileptic encephalopathy, 77 | 2015-01-13 | no assertion criteria provided | literature only | |
Biochemical Molecular Genetic Laboratory, |
RCV000850139 | SCV001469188 | likely pathogenic | Developmental and epileptic encephalopathy, 77 | 2020-09-10 | no assertion criteria provided | clinical testing |